Cell Therapy Scientist vs Gene Editing Scientist: which career is safer from AI?
Cell Therapy Scientist is the safer bet: future safety 78/100 against 74/100 for Gene Editing Scientist.
| Cell Therapy Scientist | Gene Editing Scientist | |
|---|---|---|
| AI risk by 2035 | 30/100 | 32/100 |
| Future safety | 78/100 | 74/100 |
| Jobs in India | Demand growing | Demand growing |
| Starting salary | ₹3 - ₹5 Lakh/annum | check current postings from CSIR, ICAR, IISER, universities and biotech firms be |
| First to go to AI | Keep lab notebooks and GMP batch records | Design guide RNA sequences and choose the editing tool for a target gene |
| Verdict | Safe bet for a wet-lab career: AI takes the paperwork and data crunching, not the sterile bench. | Safe core: the wet-lab and judgement work stays human, while AI takes over guide design and data crunching. |
| Salary in 2035 | ₹00 - ₹00 Lakh | ₹00 - ₹00 Lakh |
Unlock both full reports free
Free, takes 30 seconds. Already have an account? Log in
Will AI replace Cell Therapy Scientist? Full outlook →Will AI replace Gene Editing Scientist? Full outlook →
Still stuck between Cell Therapy Scientist and Gene Editing Scientist?
Two good careers can be a bad fit for the same person. The career test compares both against your interests, aptitude and personality, and a counsellor helps you decide.